Skip to main content
Premium Trial:

Request an Annual Quote

GeneLink's Q1 Revenues Rise to $2M

NEW YORK (GenomeWeb News) – GeneLink today reported that its first-quarter revenues rose to $2 million from only $26,424 for the first quarter of 2008.

The Orlando, Fla.-based consumer genomics company said in a filing with the US Securities and Exchange Commission that the dramatic rise in its revenues was due to last year's launch of its GeneWize Life Sciences business and sales of its LifeMap Nutrition System product. GeneWize is directly selling to consumers nutritional products and skin care products that the firm said is specifically tailored to an individual's genetic makeup.

GeneLink posted a net loss of $510,229 for the quarter ended March 31, compared a net loss of $448,250 for Q1 2008. The higher loss was due to sales commission expenses of $733,025 paid to sales affiliates.

GeneLink finished the quarter with cash and cash equivalents of $676,251.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.